Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method and medical application of unsaturated cyclic amine pyridine disulfide derivative

A kind of technology of pharmacy and compound, applied in the preparation field of above-mentioned compound, can solve the problems such as no literature report etc.

Inactive Publication Date: 2021-05-18
BEIJING VOBAN PHARMA TECH CO LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These patents protect a series of saturated cyclic amine derivatives and report the anti-platelet activity in vivo and in vitro, but there are no literature reports on the derivatives with unsaturated cyclic amine structure and their anti-platelet activity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and medical application of unsaturated cyclic amine pyridine disulfide derivative
  • Preparation method and medical application of unsaturated cyclic amine pyridine disulfide derivative
  • Preparation method and medical application of unsaturated cyclic amine pyridine disulfide derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0105] Synthesis of 1-trityl-4-piperidone

[0106]

[0107] In a solution of 40 g (0.260 mol) of 4-piperidone-hydrate hydrochloride and 109 mL (0.78 mol) of triethylamine in 550 mL of dimethylformamide, under stirring at 60°C, add chlorotriphenyl After 72.5 g (0.260 mol) of methane, it was stirred at this temperature for 5 h, and after cooling, the precipitated triethylamine hydrochloride was filtered. The filtrate was poured into 2500 mL of water, stirred while pouring, and after standing still, it was filtered with suction to obtain 77.7 g of white solid, with a yield of 70.2%. 1 HNMR (500MHz, CDC1 3 ):d 7.86-7.06 (m, 15H, J = 6.5Hz), 2.64 (dd, 4H, J = 7.1Hz), 2.55 (dd, 4H, J = 7.1Hz). ESI-MS m / z 364.45 [M +Na] + .

Embodiment 2

[0109] Synthesis of Ethyl E-2-(4-carbonyl-1-tritylpiperidin-3-enyl)-acetate

[0110]

[0111] Put 60g (0.1757mol) of 1-trityl-4-piperidone and 15.8mL (0.1933mol) of pyrrolidine in 600mL of toluene solution, azeotrope under reflux for 3h with water separator, add glyoxylic acid after cooling down 20.2 mL (0.1933 mol) of ethyl ester, followed by azeotropic dehydration under reflux for 2 h. After cooling, 400 mL of water was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography to obtain 49.35 g of a light yellow oily substance, with a yield of 60.2%. 1 HNMR (500MHz, CDC1 3 ):d 7.51-7.17(m, 15H), 6.59(s, 1H), 4.10(q, 2H, J=7.1Hz), 3.71(s, 2H), 2.79(t, 2H, J=6.0Hz) , 2.65(s, 2H), 1.17(t, 2H, J=7.1Hz).

[0112] ESI-MS m / z 448.1[M+Na] +

Embodiment 3

[0114] Synthesis of E-2-(4-Hydroxy-1-tritylpiperidin-3-enyl)-ethyl acetate

[0115]

[0116] Dissolve 22g (0.0517mol) of E-2-(4-carbonyl-1-tritylpiperidin-3-enyl)-ethyl acetate in 50mL of dichloromethane, add 200mL of methanol, and After adding 2.34 g (0.0619 mol) of sodium borohydride little by little, the mixture was stirred at room temperature for 1 h. After concentrating the reaction solution under reduced pressure, 150 mL of water was added, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate. The solvent was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography to obtain light yellow oil M3-7, 12.8 g, yield 57.9%, 1 HNMR (300MHz, CDC1 3 ):d 7.45(d, 6H, J=7.3Hz), 7.25-7.11(m, 9H), 6.05(s, 1H), 4.48(s, 1H), 4.14-3.96(m, 3H), 2.99(s , 1H), 2.30-2.22(m, 1H), 2.10-2.03(m, 1H), 1.93-1.85(m, 3H), 1.12(t, 3H, J=7.1Hz). ESI-MS m / z426.2[M-H] - .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicinal chemistry, in particular to a series of unsaturated cyclic amine pyridine disulfide derivatives, and further discloses a preparation method and medical application of the compounds. The invention discloses a novel unsaturated cyclic amine pyridine disulfide derivative and a preparation method and application thereof for the first time, especially for treating atherosclerotic diseases, myocardial infarction, stroke, peripheral arterial diseases, acute coronary syndromes and thrombosis in an anti-angiogenesis operation period.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a series of unsaturated cyclic amine pyridine disulfide derivatives. The invention also discloses a preparation method of the compound and its medical application. Background technique [0002] Cardiovascular and cerebrovascular thrombotic diseases are a common disease. In recent years, the incidence of thromboembolic diseases, mainly coronary artery thrombosis and cerebral thrombosis, has been on the rise, seriously endangering human health. Therefore, the prevention and treatment of such diseases Research is very important. Platelet aggregation is a key link in the normal coagulation mechanism, but the adhesion and aggregation of platelets are also the initial link of thrombus formation. Therefore, drugs that inhibit platelet aggregation play an important role in the treatment of thrombosis (Stroke, 1999, 30:878). Antiplatelet agglutination drugs have always been a research...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/12A61K31/455A61P7/02A61P9/10A61P9/00
CPCA61P7/02A61P9/00A61P9/10C07B2200/07C07D401/12
Inventor 艾海马张卫锋冯美香王磊贾晓栋
Owner BEIJING VOBAN PHARMA TECH CO LTD